Latest Insider Transactions at Evofem Biosciences, Inc. (EVFM)
This section provides a real-time view of insider transactions for Evofem Biosciences, Inc. (EVFM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Evofem Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Evofem Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 12
2024
|
Yan Zhang CFO |
SELL
Open market or private sale
|
Direct |
104
-100.0%
|
$0
$0.04 P/Share
|
|
Dec 21
2023
|
Kim P. Kamdar Director |
SELL
Open market or private sale
|
Direct |
10
-100.0%
|
$0
$0.62 P/Share
|
|
Dec 31
2022
|
Saundra L Pelletier Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50,000
-21.12%
|
-
|
|
May 27
2022
|
Saundra L Pelletier Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
141,000
+37.33%
|
$0
$0.35 P/Share
|
|
Feb 18
2022
|
Saundra L Pelletier Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+34.31%
|
-
|
|
Feb 18
2022
|
Justin J. File Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
450,000
+35.69%
|
-
|
|
Feb 18
2022
|
Alexander A Fitzpatrick General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+36.75%
|
-
|
|
Dec 31
2021
|
Saundra L Pelletier Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
300,000
-30.43%
|
-
|
|
Dec 31
2021
|
Justin J. File Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
120,000
-24.95%
|
-
|
|
Dec 31
2021
|
Alexander A Fitzpatrick General Counsel and Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
120,000
-35.67%
|
-
|
|
Dec 20
2021
|
Saundra L Pelletier Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
135,000
+12.04%
|
$0
$0.38 P/Share
|
|
Dec 20
2021
|
Justin J. File Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
40,594
+7.78%
|
$0
$0.37 P/Share
|
|
Dec 20
2021
|
Alexander A Fitzpatrick General Counsel and Secretary |
BUY
Open market or private purchase
|
Direct |
25,000
+6.92%
|
$0
$0.39 P/Share
|
|
Jul 08
2021
|
Russell Barrans Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,998
-4.27%
|
$0
$0.98 P/Share
|
|
Jun 18
2021
|
Kim P. Kamdar Director |
BUY
Open market or private purchase
|
Direct |
10,000
+34.14%
|
$10,000
$1.17 P/Share
|
|
Jun 14
2021
|
Anthony Stephen O'Brien Director |
BUY
Open market or private purchase
|
Direct |
8,140
+50.0%
|
$8,140
$1.31 P/Share
|
|
Jun 11
2021
|
Lisa Dale Rarick Director |
BUY
Open market or private purchase
|
Direct |
5,000
+32.79%
|
$5,000
$1.2 P/Share
|
|
Jun 11
2021
|
Russell Barrans Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
18,180
+3.74%
|
$18,180
$1.14 P/Share
|
|
Jun 10
2021
|
Alexander A Fitzpatrick General Counsel and Secretary |
BUY
Open market or private purchase
|
Direct |
10,000
+3.11%
|
$10,000
$1.02 P/Share
|
|
Jun 10
2021
|
Saundra L Pelletier Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+5.55%
|
$50,000
$1.03 P/Share
|
|
Jun 10
2021
|
Justin J. File Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
24,500
+5.27%
|
$24,500
$1.03 P/Share
|
|
May 20
2021
|
Saundra L Pelletier Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
105,300
-11.62%
|
$0
$0.86 P/Share
|
|
May 20
2021
|
Justin J. File Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
42,280
-9.23%
|
$0
$0.86 P/Share
|
|
May 20
2021
|
Kelly Culwell Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
42,061
-13.33%
|
$0
$0.86 P/Share
|
|
May 20
2021
|
Russell Barrans Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
31,480
-6.53%
|
$0
$0.86 P/Share
|
|
May 20
2021
|
Alexander A Fitzpatrick General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
42,120
-12.26%
|
$0
$0.86 P/Share
|
|
Mar 09
2021
|
Saundra L Pelletier Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
45,249
+4.76%
|
$90,498
$2.28 P/Share
|
|
Feb 03
2021
|
Kelly Culwell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+38.8%
|
-
|
|
Feb 03
2021
|
Alexander A Fitzpatrick General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+36.8%
|
-
|
|
Feb 03
2021
|
Justin J. File Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+30.39%
|
-
|
|
Feb 03
2021
|
Russell Barrans Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+29.33%
|
-
|
|
Feb 03
2021
|
Saundra L Pelletier Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+36.74%
|
-
|
|
Nov 17
2020
|
Alexander A Fitzpatrick General Counsel and Secretary |
BUY
Open market or private purchase
|
Direct |
9,090
+5.96%
|
$18,180
$2.2 P/Share
|
|
Nov 17
2020
|
Justin J. File Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
7,760
+2.92%
|
$15,520
$2.17 P/Share
|
|
Jun 05
2020
|
Invesco Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
857,143
+6.09%
|
$2,571,429
$3.5 P/Share
|
|
Jun 04
2020
|
Acacia Research Corp > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,138,504
-99.99%
|
$27,415,512
$3.21 P/Share
|
|
May 26
2020
|
Invesco Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
73,879
-0.3%
|
$369,395
$5.89 P/Share
|
|
May 15
2020
|
Invesco Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,211
-0.03%
|
$16,055
$5.04 P/Share
|
|
May 14
2020
|
Invesco Ltd. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
78,013
+0.62%
|
$390,065
$5.13 P/Share
|
|
Jun 10
2019
|
Invesco Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,222,222
+15.83%
|
$8,888,888
$4.5 P/Share
|
|
Feb 08
2019
|
Invesco Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
425,531
+4.25%
|
$851,062
$2.64 P/Share
|